Kolexia
Maison Patrick Santé publique
Maison Patrick
Santé publique
Hôpital Henri Mondor
Créteil, France
76 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie de Huntington Effets secondaires indésirables des médicaments Hypertension artérielle Grippe humaine Syndrome de Stevens-Johnson Acromégalie Défaillance cardiaque Insuffisance tricuspide Hyperprolactinémie

Collaborateurs

Voir plus
Bachoud-Levi Anne
Bachoud-Levi Anne
Hôpital Henri Mondor, Créteil, France
Macquin-Mavier Isabelle
Macquin-Mavier Isabelle
Assistance publique – Hôpitaux de Paris, Issy-les-Moulineaux, France
Verny Christophe
Verny Christophe
Hôpital Larrey Angers, Angers, France
Youssov Katia
Youssov Katia
Hôpital Henri Mondor, Créteil, France

Industries

Voir plus
{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Prevention and management of health products shortages by the French national agency (ANSM), 10 years of experience.
Frontiers in public health   17 novembre 2023
Clinical Trial Authorisation: A Final Look Back to Better Appraise the New European Regulation.
Reviews on recent clinical trials   29 août 2023
Patient and public involvement in the benefit-risk assessment and decision concerning health products: position of the Scientific Advisory Board of the French National Agency for Medicines and Health Products Safety (ANSM).
BMJ global health   22 mai 2023
Estimation of the influenza-associated respiratory hospitalization burden using sentinel surveillance data, Lebanon, 2015-2020.
Influenza and other respiratory viruses   23 avril 2023
Regulatory assessment of nano-enabled health products in public health interest. Position of the scientific advisory board of the French National Agency for the Safety of Medicines and Health Products.
Frontiers in public health   02 mars 2023
Prevalence of medication administration errors in hospitalized adults: A systematic review and meta-analysis up to 2017 to explore sources of heterogeneity.
Fundamental & clinical pharmacology   15 février 2023
Patient involvement in pharmacovigilance: determinants and evolution of reporting from 2011 to 2020 in France.
European journal of clinical pharmacology   12 décembre 2022
3e rendez-vous de l’engagement des usagers, des personnes accompagnées - 22/11/22
Youtube @ HAS - Haute Autorité de santé   24 novembre 2022
Syndrome de duplication/délétion inversée du bras court du chromosome 8
HAS Publications   10 octobre 2022
Authorization of COVID-19 clinical trials: lessons from 2 years of experience of a national competent authority.
Frontiers in pharmacology   15 août 2022